(Q34216512)

31 July 2017

title

Low-dose naltrexone for pruritus in systemic sclerosis (English)

1 reference

31 July 2017

0 references

0 references

4

Maureen Murtaugh

1 reference

31 July 2017

Tracy Frech

1

1 reference

31 July 2017

Kirsten Novak

2

1 reference

31 July 2017

Monica P Revelo

3

1 reference

31 July 2017

Boaz Markewitz

5

1 reference

31 July 2017

Nathan Hatton

6

1 reference

31 July 2017

Mary Beth Scholand

7

1 reference

31 July 2017

Edward Frech

8

1 reference

31 July 2017

David Markewitz

9

1 reference

31 July 2017

Allen D Sawitzke

10

1 reference

31 July 2017

publication date

12 September 2011

1 reference

International journal of rheumatology

31 July 2017

published in

1 reference

31 July 2017

volume

2011

1 reference

31 July 2017

page(s)

804296

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The role of eosinophils and mast cells in intestinal functional disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Skin involvement in systemic autoimmune diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Primary biliary cirrhosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Low-dose naltrexone therapy improves active Crohn's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Clinical manifestations of systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

On scleroderma. Mast cells, endothelial cells, and fibroblasts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Systemic sclerosis. The role of the mast cell and cytokines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171757

Prevalence and clinical correlates of pruritus in patients with systemic sclerosis

28 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Association of pruritus with quality of life and disability in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F804296

Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria

21 January 2018

1 reference

12 December 2020

Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease

1 reference

12 December 2020

Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument

1 reference

12 December 2020

Pathogenese des Pruritus

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/804296

1 reference

31 July 2017

1 reference

31 July 2017

1 reference